MindBio Therapeutics (XCNQ:MBIO) Beginning Cash Position : C$0.09 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Beginning Cash Position?

MindBio Therapeutics's Beginning Cash Position for the quarter that ended in Mar. 2024 was C$0.09 Mil.

MindBio Therapeutics's quarterly Beginning Cash Position declined from Sep. 2023 (C$0.28 Mil) to Dec. 2023 (C$0.21 Mil) and declined from Dec. 2023 (C$0.21 Mil) to Mar. 2024 (C$0.09 Mil).

MindBio Therapeutics's annual Beginning Cash Position increased from Jun. 2021 (C$0.00 Mil) to Jun. 2022 (C$0.43 Mil) and increased from Jun. 2022 (C$0.43 Mil) to Jun. 2023 (C$1.17 Mil).

MindBio Therapeutics Beginning Cash Position Historical Data

The historical data trend for MindBio Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Beginning Cash Position Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Beginning Cash Position

0.43

1.17

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial					0.14	0.33	0.28	0.21	0.09

MindBio Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

MindBio Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.